Cargando…

Systemic reactogenicity following homologues and heterologous prime-boost AZD1222 and BNT162b2 COVID-19 vaccination of 2862 healthcare workers compared with an unvaccinated population

During spring 2021, AZD1222 and BNT162b2 were used as prime and BNT162b2 as booster COVID-19 vaccines in Denmark. We obtained self-reported information on systemic reactogenicity day-by-day during two weeks for 2862 healthcare workers vaccinated with heterologous AZD1222 + BNT162b2 or homologous BNT...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabatabaeifar, Sorosh, Vestergaard, Jesper M., Würtz, Else T., Hansen, Karoline K., Nielsen, Kent J., Schlünssen, Vivi, Kolstad, Henrik A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010832/
https://www.ncbi.nlm.nih.gov/pubmed/36945661
http://dx.doi.org/10.1016/j.jvacx.2023.100280
_version_ 1784906259824115712
author Tabatabaeifar, Sorosh
Vestergaard, Jesper M.
Würtz, Else T.
Hansen, Karoline K.
Nielsen, Kent J.
Schlünssen, Vivi
Kolstad, Henrik A.
author_facet Tabatabaeifar, Sorosh
Vestergaard, Jesper M.
Würtz, Else T.
Hansen, Karoline K.
Nielsen, Kent J.
Schlünssen, Vivi
Kolstad, Henrik A.
author_sort Tabatabaeifar, Sorosh
collection PubMed
description During spring 2021, AZD1222 and BNT162b2 were used as prime and BNT162b2 as booster COVID-19 vaccines in Denmark. We obtained self-reported information on systemic reactogenicity day-by-day during two weeks for 2862 healthcare workers vaccinated with heterologous AZD1222 + BNT162b2 or homologous BNT162b2 + BNT162b2 regimens and compared prevalences of symptoms with unvaccinated healthcare workers. We found comparable systemic reactogenicity during the first week in the two vaccine regimens and no reactogenicity during the second week. Most of the symptoms returned to a level equal to the control population four days after booster vaccination.
format Online
Article
Text
id pubmed-10010832
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-100108322023-03-14 Systemic reactogenicity following homologues and heterologous prime-boost AZD1222 and BNT162b2 COVID-19 vaccination of 2862 healthcare workers compared with an unvaccinated population Tabatabaeifar, Sorosh Vestergaard, Jesper M. Würtz, Else T. Hansen, Karoline K. Nielsen, Kent J. Schlünssen, Vivi Kolstad, Henrik A. Vaccine X Short communication During spring 2021, AZD1222 and BNT162b2 were used as prime and BNT162b2 as booster COVID-19 vaccines in Denmark. We obtained self-reported information on systemic reactogenicity day-by-day during two weeks for 2862 healthcare workers vaccinated with heterologous AZD1222 + BNT162b2 or homologous BNT162b2 + BNT162b2 regimens and compared prevalences of symptoms with unvaccinated healthcare workers. We found comparable systemic reactogenicity during the first week in the two vaccine regimens and no reactogenicity during the second week. Most of the symptoms returned to a level equal to the control population four days after booster vaccination. Elsevier 2023-03-14 /pmc/articles/PMC10010832/ /pubmed/36945661 http://dx.doi.org/10.1016/j.jvacx.2023.100280 Text en © 2023 The Author(s)
spellingShingle Short communication
Tabatabaeifar, Sorosh
Vestergaard, Jesper M.
Würtz, Else T.
Hansen, Karoline K.
Nielsen, Kent J.
Schlünssen, Vivi
Kolstad, Henrik A.
Systemic reactogenicity following homologues and heterologous prime-boost AZD1222 and BNT162b2 COVID-19 vaccination of 2862 healthcare workers compared with an unvaccinated population
title Systemic reactogenicity following homologues and heterologous prime-boost AZD1222 and BNT162b2 COVID-19 vaccination of 2862 healthcare workers compared with an unvaccinated population
title_full Systemic reactogenicity following homologues and heterologous prime-boost AZD1222 and BNT162b2 COVID-19 vaccination of 2862 healthcare workers compared with an unvaccinated population
title_fullStr Systemic reactogenicity following homologues and heterologous prime-boost AZD1222 and BNT162b2 COVID-19 vaccination of 2862 healthcare workers compared with an unvaccinated population
title_full_unstemmed Systemic reactogenicity following homologues and heterologous prime-boost AZD1222 and BNT162b2 COVID-19 vaccination of 2862 healthcare workers compared with an unvaccinated population
title_short Systemic reactogenicity following homologues and heterologous prime-boost AZD1222 and BNT162b2 COVID-19 vaccination of 2862 healthcare workers compared with an unvaccinated population
title_sort systemic reactogenicity following homologues and heterologous prime-boost azd1222 and bnt162b2 covid-19 vaccination of 2862 healthcare workers compared with an unvaccinated population
topic Short communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010832/
https://www.ncbi.nlm.nih.gov/pubmed/36945661
http://dx.doi.org/10.1016/j.jvacx.2023.100280
work_keys_str_mv AT tabatabaeifarsorosh systemicreactogenicityfollowinghomologuesandheterologousprimeboostazd1222andbnt162b2covid19vaccinationof2862healthcareworkerscomparedwithanunvaccinatedpopulation
AT vestergaardjesperm systemicreactogenicityfollowinghomologuesandheterologousprimeboostazd1222andbnt162b2covid19vaccinationof2862healthcareworkerscomparedwithanunvaccinatedpopulation
AT wurtzelset systemicreactogenicityfollowinghomologuesandheterologousprimeboostazd1222andbnt162b2covid19vaccinationof2862healthcareworkerscomparedwithanunvaccinatedpopulation
AT hansenkarolinek systemicreactogenicityfollowinghomologuesandheterologousprimeboostazd1222andbnt162b2covid19vaccinationof2862healthcareworkerscomparedwithanunvaccinatedpopulation
AT nielsenkentj systemicreactogenicityfollowinghomologuesandheterologousprimeboostazd1222andbnt162b2covid19vaccinationof2862healthcareworkerscomparedwithanunvaccinatedpopulation
AT schlunssenvivi systemicreactogenicityfollowinghomologuesandheterologousprimeboostazd1222andbnt162b2covid19vaccinationof2862healthcareworkerscomparedwithanunvaccinatedpopulation
AT kolstadhenrika systemicreactogenicityfollowinghomologuesandheterologousprimeboostazd1222andbnt162b2covid19vaccinationof2862healthcareworkerscomparedwithanunvaccinatedpopulation